Mohd Nubli Mustapa
1PUBLICATIONS
0CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Mar 06, 2026
Phase 2a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of londamocitinib (AZD4604) two times per day for 12 weeks in adult patients with moderate-to-severe asthma uncontrolled on medium-high-dose ICS-LABA.Mohd Nubli Mustapa, Rod Hughes, Tina J Jensen
Pageof 1
